Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000950170-25-002171
Filing Date
2025-01-06
Accepted
2025-01-06 16:29:47
Documents
2
Period of Report
2024-12-20

Document Format Files

Seq Description Document Type Size
1 3 ownership.html 3  
1 3 ownership.xml 3 8956
2 EX-24 vinc-ex24.htm EX-24 12395
  Complete submission text file 0000950170-25-002171.txt   22961
Mailing Address C/O VERSARTIS, INC. 1020 MARSH ROAD MENLO PARK CA 94025
Business Address
Haas Kevin (Reporting) CIK: 0001723780 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39244 | Film No.: 25511587

Mailing Address 260 SHERIDAN AVENUE SUITE 400 PALO ALTO CA 94306
Business Address 260 SHERIDAN AVENUE SUITE 400 PALO ALTO CA 94306 650-800-6676
Vincerx Pharma, Inc. (Issuer) CIK: 0001796129 (see all company filings)

EIN.: 833197402 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)